Search results - 2 results

Annual report Belgian Cystic Fibrosis Registry 2016

been a steady 14 Summ ar y increase in the prevalence of Achromobacter xylosoxidans from 5.9% in 2009 stabilizing at prevalence levels above 10.0% since 2012. Thanks to improved disease management ...

The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease

should be clearly identified and given full support, as this burden is likely to increase in the future, especially from an economic perspective. Our study may also contribute towards a better global ...

QR code

QR code for this page URL